XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jul. 01, 2018
Dec. 31, 2017
Current assets:    
Cash $ 20,285 $ 18,241
Restricted Cash 464 89
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts of $283 and $292, Respectively 15,468 14,657
Inventories, Net 24,861 26,326
Prepaid Expenses and Other Current Assets 2,445 2,603
Total Current Assets 63,523 61,916
Property, Equipment and Improvements, Net 8,056 7,570
Goodwill 20,322 20,458
Other Intangible Assets, Net 6,805 7,085
Deferred Income Taxes 32 32
Other Non-Current Assets 107 125
Total Assets 98,845 97,186
Current Liabilities:    
Accounts Payable 6,656 8,787
Accrued Compensation and Related Benefits 1,711 2,413
Accrued Expenses and Other Current Liabilities 2,347 2,871
Income Taxes Payable 140 168
Total Current Liabilities 10,854 14,239
Deferred Income Taxes 3,891 3,867
Other Non-Current Liabilities 32 31
Total Liabilities 14,777 18,137
Commitments and Contingencies (Note 11)
Shareholders' Equity:    
Preferred Stock – Par Value $.10 Per Share; Authorized 1,000,000 Shares; None Issued
Common Stock – Par Value $.10 Per Share; Authorized 40,000,000 Shares; Issued – 19,961,404 Shares at July 1, 2018 and 19,670,928 Shares at December 31, 2017; Outstanding – 15,941,693 Shares at July 1, 2018 and 15,651,217 Shares at December 31, 2017 1,996 1,966
Capital in Excess of Par Value 181,818 180,211
Accumulated Deficit (79,117) (82,894)
Accumulated Other Comprehensive Loss (2,036) (1,611)
Treasury Stock - At Cost; 4,019,711 Shares (18,469) (18,469)
Total Ultralife Corporation Equity 84,192 79,203
Non-Controlling Interest (124) (154)
Total Shareholders’ Equity 84,068 79,049
Total Liabilities and Shareholders' Equity $ 98,845 $ 97,186